Pharsight

Polarean patents expiration

1. Xenoview patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10583205 POLAREAN Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices
Feb, 2035

(10 years from now)

US11052161 POLAREAN Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices
Dec, 2035

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Dec 23, 2027

Drugs and Companies using XENON XE-129 HYPERPOLARIZED ingredient

NCE-1 date: 2026-12-23

Market Authorisation Date: 23 December, 2022

Treatment: NA

Dosage: GAS;INHALATION

More Information on Dosage

XENOVIEW family patents

Family Patents